ARK Genomic Revolution ETF $ARKG Shares Newly Acquired by Canal Insurance CO

Canal Insurance CO purchased a new position in shares of ARK Genomic Revolution ETF (BATS:ARKG) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 120,000 shares of the company’s stock, valued at approximately $6,517,000. ARK Genomic Revolution ETF comprises about 1.5% of Canal Insurance CO’s investment portfolio, making the stock its 20th largest position.

Other hedge funds have also recently modified their holdings of the company. NewEdge Advisors LLC boosted its holdings in ARK Genomic Revolution ETF by 102.6% in the 1st quarter. NewEdge Advisors LLC now owns 24,092 shares of the company’s stock worth $637,000 after buying an additional 12,202 shares during the last quarter. Nwam LLC increased its stake in ARK Genomic Revolution ETF by 55.3% during the 2nd quarter. Nwam LLC now owns 31,704 shares of the company’s stock worth $1,333,000 after buying an additional 11,294 shares in the last quarter. Group One Trading LLC raised its holdings in shares of ARK Genomic Revolution ETF by 168.3% during the first quarter. Group One Trading LLC now owns 45,861 shares of the company’s stock valued at $1,212,000 after acquiring an additional 28,765 shares during the last quarter. Gimbal Financial acquired a new position in shares of ARK Genomic Revolution ETF during the third quarter valued at approximately $6,478,000. Finally, Moran Wealth Management LLC raised its holdings in shares of ARK Genomic Revolution ETF by 79.6% during the first quarter. Moran Wealth Management LLC now owns 49,204 shares of the company’s stock valued at $1,300,000 after acquiring an additional 21,811 shares during the last quarter.

ARK Genomic Revolution ETF Stock Performance

Shares of BATS ARKG traded up $1.50 during midday trading on Tuesday, hitting $48.87. The stock had a trading volume of 3,269,506 shares, compared to its average volume of 3,380,569. The stock has a 50 day simple moving average of $48.93 and a 200-day simple moving average of $39.66. ARK Genomic Revolution ETF has a 1 year low of $24.60 and a 1 year high of $58.83.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.